神经影像遗传学方法识别孤独症谱系障碍早期诊断新生物标志物
本文综述神经影像遗传学方法在孤独症谱系障碍(ASD)早期诊断生物标志物识别中的应用。文章讨论该方法有助于识别影响脑回路结构与功能变异的ASD风险基因,并通过阐明遗传风险的机制与通路验证生物学改变。整合人工智能模型与神经影像数据可为ASD的准确诊断奠定基础并促进早期诊断生物标志物的识别。
要点
- 神经影像遗传学可识别影响脑回路结构与功能变异的ASD风险基因。
- 该方法通过阐明遗传风险的机制与通路验证生物学改变。
- 整合人工智能模型与神经影像数据有助于ASD早期诊断生物标志物识别。
核心结论
- 神经影像遗传学方法有助于理解ASD中神经化学系统与分子通路的扰动,并可检测结构、功能与代谢改变,促进ASD早期诊断新生物标志物的发现。
研究设计与样本
- 本文为综述,讨论神经影像遗传学方法在ASD早期诊断生物标志物识别中的意义。
主要发现
- 神经影像遗传学有助于识别影响脑回路结构与功能变异的ASD风险基因。
- 该方法通过阐明赋予遗传风险的机制与通路来验证生物学改变。
- 整合人工智能模型与神经影像数据为准确诊断奠定基础并促进早期诊断生物标志物识别。
临床怎么用
- 临床可关注神经影像遗传学与人工智能结合用于ASD早期诊断生物标志物识别的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autism-spectrum disorders (ASDs) are developmental disabilities that manifest in early childhood and are characterized by qualitative abnormalities in social behaviors, communication skills, and restrictive or repetitive behaviors. To explore the neurobiological mechanisms in ASD, extensive research has been done to identify potential diagnostic biomarkers through a neuroimaging genetics approach. Neuroimaging genetics helps to identify ASD-risk genes that contribute to structural and functional variations in brain circuitry and validate biological changes by elucidating the mechanisms and pathways that confer genetic risk. Integrating artificial intelligence models with neuroimaging data lays the groundwork for accurate diagnosis and facilitates the identification of early diagnostic biomarkers for ASD. This review discusses the significance of neuroimaging genetics approaches to gaining a better understanding of the perturbed neurochemical system and molecular pathways in ASD and how these approaches can detect structural, functional, and metabolic changes and lead to the discovery of novel biomarkers for the early diagnosis of ASD.
引用
- Nisar S, Haris M. Neuroimaging genetics approaches to identify new biomarkers for the early diagnosis of autism spectrum disorder. Mol Psychiatry. 2023. PMID: 37069342. doi:10.1038/s41380-023-02060-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。